Pro Medicus Secures Major Contract Renewal with Ohio State Medical Centre
Pro Medicus Limited (ASX: PME) has strengthened its position in the healthcare imaging sector after securing a five-year contract renewal valued at approximately AU$16 million with The Ohio State University Wexner Medical Center (OSUWMC). The renewed agreement expands the existing partnership by incorporating the company's advanced Visage 7 Workflow and Visage 7 Cardiology Imaging solutions into the medical centre's imaging ecosystem.
The contract operates under a transaction-based pricing structure, offering potential revenue growth beyond the minimum contracted value. The renewal also includes improved commercial terms, featuring higher minimum commitments and increased transaction fees. Management noted that the agreement reflects continued customer confidence in the company's enterprise imaging platform and its ability to replace legacy healthcare imaging systems. The deal contributes significantly to Pro Medicus' contract renewal achievements during the financial year and highlights the company's strong client retention record. The renewal further reinforces the growing demand for scalable, cloud-enabled medical imaging solutions worldwide.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Pro Medicus Secures Major Contract Renewal with Ohio State Medical Centre
Pro Medicus Limited (ASX: PME) has strengthened its position in the healthcare imaging sector after securing a five-year contract renewal valued at approximately AU$16 million with The Ohio State University Wexner Medical Center (OSUWMC). The renewed agreement expands the existing partnership by incorporating the company's advanced Visage 7 Workflow and Visage 7 Cardiology Imaging solutions into the medical centre's imaging ecosystem.
The contract operates under a transaction-based pricing structure, offering potential revenue growth beyond the minimum contracted value. The renewal also includes improved commercial terms, featuring higher minimum commitments and increased transaction fees. Management noted that the agreement reflects continued customer confidence in the company's enterprise imaging platform and its ability to replace legacy healthcare imaging systems. The deal contributes significantly to Pro Medicus' contract renewal achievements during the financial year and highlights the company's strong client retention record. The renewal further reinforces the growing demand for scalable, cloud-enabled medical imaging solutions worldwide.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au